Sentences with phrase «of asthma drug»

Leukotriene pathway modifiers, also known as leukotriene blockers, are a relatively new type of asthma drug.

In the new study, the lab has conducted the first large - scale whole genome sequencing study of asthma drug response in African Americans and Latino children in an effort to pin down the genetic factors contributing to reduced albuterol response more precisely than possible in previous association studies.

There is a dizzying array of asthma drugs that can be taken in multiple ways, so it helps to take notes.

Not exact matches

RESEARCHERS at Curtin University have commenced a project to develop a new generation of drugs for treatment of HIV - AIDS, asthma and melanoma.

Thus Rich Demont, who won the 400 - meter freestyle swim race, was disqualified when it was discovered that he had traces of a drug used for asthma in his system.

To quote this site «The American College of Allergy, Asthma & Immunology (ACAAI) states: «Coconut is not a botanical nut; it is classified as a fruit, even though the Food and Drug Administration recognizes coconut as a tree nut.

I would hope any adult or child who has been given a mood associated disorder such as ADHD, ADD or anxiety / depression or a respiratory diagnosis such as asthma, would try a paleo diet before they let themselves think there is no hope of life without prescription drugs.

It also doesn't say squat about the literally hundreds of other things you could worry about (like kids with allergies and asthma getting their hands on certain foods, the host taking the kids in a car without a car seat, a backyard trampoline, alcohol / drugs left around the house, playing in the front yard abutting a very busy street, etc. etc. etc.) It's just meant to talk about your child's preparedness for being away from mom and dad.

Breech Twins and higher order multiples Previous CS Pre-Eclampsia Placenta praevia Cervical incompetence Previous late stillbirth Previous premature birth Grand multiparty Age under 18 Age over 35 Smoking Drug use Severe mental health issue Epilepsy Type 1 diabetes Type 2 diabetes Gestational diabetes Asthma GBS positive Abnormal antibodies Transplant recipient Congenital heart disease Known foetal abnormality Immunosuppressive medication MS Physical disability Intellectual disability Hypothyroidism Hyperthyroidism Previous shoulder dystocia Previous 3rd or 4th degree tear Sickle Cell anaemia BMI under 18 or over 35 at conception Previous massive PPH APH in current pregnancy HIV / AIDS Hepatitis B or C Active TB IUGR Oligohydramnios Polyhydramnios Child previously removed from custody because of abuse Uterine abnormalities such as uterine septum or double uterus Previous uterine surgery for fibroids Chronic renal problems Hypertension Auto immune condition Previous stroke or blod clot Cancer Domestic violence or abusive home Prisoners Homeless women

(borrowed from Dr Kitty) Breech Twins and higher order multiples Previous CS Pre-Eclampsia Placenta praevia Cervical incompetence Previous late stillbirth Previous premature birth Grand multiparty Age under 18 Age over 35 Smoking Drug use Severe mental health issue Epilepsy Type 1 diabetes Type 2 diabetes Gestational diabetes Asthma GBS positive Abnormal antibodies Transplant recipient Congenital heart disease Known foetal abnormality Immunosuppressive medication MS Physical disability Intellectual disability Hypothyroidism Hyperthyroidism Previous shoulder dystocia Previous 3rd or 4th degree tear Sickle Cell anaemia BMI under 18 or over 35 at conception Previous massive PPH APH in current pregnancy HIV / AIDS Hepatitis B or C Active TB IUGR Oligohydramnios Polyhydramnios Child previously removed from custody because of abuse Uterine abnormalities such as uterine septum or double uterus Previous uterine surgery for fibroids Chronic renal problems Hypertension Auto immune condition Previous stroke or blod clot Cancer Domestic violence or abusive home Prisoners Homeless women

The San Diego, California — based biotech company MediciNova recently completed a phase II trial of a glia - inhibiting drug called ibudilast, already approved as an asthma treatment in Japan, to relieve pain and treat withdrawal in opioid abusers.

«In the study we used drug doses equivalent to those used in the treatment of asthma patients.»

After the lawsuits were filed, Minyard amended the autopsy report, changing Miceli's cause of death from a drug overdose to asthma and labeling it a natural death.

«Asthma drugs could prevent prevent deadly form of pneumonia, research suggests: Early administration may block infection of important cells deep in the lungs.»

Two drugs used to treat asthma and allergies may offer a way to prevent a form of pneumonia that can kill up to 40 percent of people who contract it, researchers at the University of Virginia School of Medicine have found.

But early administration of the two asthma drugs, Accolate and Singulair, could prevent the infection of the alveolar cells deep in the lower respiratory tract, Braciale's research suggests.

A person with a mild reaction to the drug may break out in hives, but more severe signs can occur, including swelling of the lips, tongue and throat, as well as asthma - like symptoms.

Heart disease was the leading cause of death for 2016, followed by cancer, unintentional injuries such as drug overdoses and car crashes, chronic lower respiratory diseases including asthma, and stroke.

Scientists have discovered over 30 new genes that predispose people to allergies and asthma, some of which could be targets for new drugs.

New classes of drugs that target allergic asthma are emerging or close to market, but Levy notes that these new drugs are unlikely to help patients with non-type 2 inflammation in severe asthma.

In patients admitted to the hospital for asthma, illicit drug use and low socioeconomic status were linked with an increased risk of requiring admission to the intensive care unit.

«Not only does this report shed light on how colds exacerbate asthma, it also suggests new pathways and existing drugs that might be exploited to limit this, in some cases, severe combination of respiratory events,» said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology, «These findings also highlight an emerging appreciation for the interaction between metabolic pathways and the immune system.»

People must buy blood pressure or asthma drugs for years, but only one or a few doses of a vaccine in their lives, so sales are low.

«By the actions of corticosteroids on NK cells, patients with severe asthma who are on corticosteroids may be experiencing the side effects of the drug without receiving significant benefit,» said Levy.

«Illicit drug use can lead to poor self - management of asthma, and predispose to life - threatening asthma attacks.

This translates into more accurate diagnostics, new therapy strategies and the development of patient - focused drugs that can target the different subgroups of asthma.

In a letter to the British Medical Journal, New Zealand researchers say the trend supports their argument that fenoterol, a drug used to relieve acute attacks, was a major factor in the epidemic of asthma deaths in the country in the 1980s.

However, for a small subgroup of people with asthma, LABAs can cause severe, life - threatening side effects and carry a boxed safety warning from the U.S. Food and Drug Administration.

An explosion of recent studies in both animals and people suggests that resident microbes can influence susceptibility to diseases from HIV to asthma, predispose to obesity across generations, and tinker with how the body responds to drugs.

A team of researchers at McMaster University and St. Joseph's Healthcare Hamilton have successfully evaluated a new, antibody - based drug for certain patients with severe asthma.

Many of the people who take current asthma drugs, called beta - 2 agonists, become less sensitive to them.

GlaxoSmithKline, which makes Advair for asthma, Lovaza for high triglyceride levels and the diabetes drug Avandia, is under pressure facing all drug companies for greater transparency in payments to doctors, a provision of Obamacare

Around half of all prescribed drugs act on these receptors, with GPCRs helping in the treatment of widespread diseases such as hypertension, asthma and Parkinson's disease.

The presentation sheds light on adverse responses to topical skin preparations; helps identify patients who are hypersensitive to antihistamines, and identifies allergic responses to various drugs used in the treatment of asthma.

Each study compared the risk of asthma for children of women taking these drugs with that for children of pregnant women who did not take these drugs and showed that these medications were associated with an increased risk of asthma.

Cancer treatments dominate the list, but since 2011 the U.S. Food and Drug Administration has approved new protein - based biologics for the treatment of Lupus, Crohn's disease, rheumatoid arthritis, multiple sclerosis, kidney failure, asthma and high cholesterol.

«This is sure to spark major new efforts toward the development of vaccines and antiviral drugs, particularly for the prevention of asthma.»

Data on patients receiving active drug in the trial were consistent with a dose - dependent improvement in some parameters of lung function examined in the study, including methacholine challenge test and peak expiratory flow rates, as well as in a biomarker associated with asthma severity and inflammation.

The next step, Srivastava said, is clinical trials of the drugs as a therapy for asthma and COPD — a process that should be expedited since aldose reductase inhibitors have already undergone Phase III clinical trials for diabetic neuropathy.

Reykjavik, ICELAND, December 17, 2004 — deCODE genetics (Nasdaq: DCGN) today announced the signing of an agreement under which it will conduct a Phase II information - rich clinical trial next year of a third - party compound as part of a drug development program in asthma.

Children with asthma experience difficulty breathing as a result of chronic inflammation of the airways, which can be alleviated by inhaling drugs called bronchodilators that make the muscles lining the airways relax, allowing them to reopen.

A discovery by Dr. Xian C. Li, the director of the Immunobiology & Transplant Science Center at Houston Methodist Research Institute, and his colleagues could lead to better drugs to treat asthma (Credit: Houston Methodist Research Institute)

In the U.S., Puerto Rican and African - American children — who also have the highest prevalence of asthma nationwide — respond least well to these life - saving drugs.

deCODE is continuing its research on both phenotypes to identify and analyze the roles of these genes, with the aim of finding novel diagnostic markers as well as drug targets that can be used to combat asthma and allergies by going to the underlying causes of both conditions.

Novel drug therapies and novel indications of drug therapy, e.g. tyrosine kinase inhibitors in lung disease other than lung cancer, biological treatments for asthma, COPD, cystic fibrosis and interstitial lung disease.

Stephen Alexander, UK - Cannabinoid receptors, transporters, endocannabinoid turnover, hydrogen sulphide turnover Arthur Christopoulos, Australia (GPCRs Liaison)- G protein - coupled receptors; analytical pharmacology; allosteric modulation; biased agonism; drug discovery; neuropharmacology John Cidlowski, USA (NHRs Liaison)- Glucocorticoid receptor signaling; apoptosis and the immune system Anthony P. Davenport, UK (Chair Evolving Pharmacology, GPCRs Liaison) Doriano Fabbro, Switzerland - Kinases and their biology, kinase inhibitors, drug discovery, pharmacology of drugs (kinase inhibitors) in the indication oncology, biology of oncology Kozo Kaibuchi, Japan Yoshikatsu Kanai, Japan - Transporters, amino acid signals, epithelial function, cancer biology Francesca Levi - Schaffer, Israel - eosinophils and mast cells as effector cells in allergic inflammation: characterization of new receptors / ligands, hypoxia / angiogenesis and eosinophils, asthma, atopic dermatitis, allergic rhinitis, immunopharmacological modulation of allergic diseases by bispecific recombinant antibodies, bacteria interactions with eosinophils and mast cells, the allergic effector unit, mast cell derived tumors: new antibody based treatment, the allergic inflammation and the resolvome, non IgE - mediated mast cell activation in diseases Eliot H. Ohlstein, USA (Editor)- Drug discovery and development, urogenital biology, cardiovascular / metabolic medicine John A. Peters, UK (LGICs Liaison) Alex Phipps, UK - Oncology, Clinical Pharmacology, Biologics and Immunotherapy Joerg Striessnig, Austria (VGICs Liaison)- Physiology, pharmacology and pathophysiological role of voltage-gated calcium chandrug discovery; neuropharmacology John Cidlowski, USA (NHRs Liaison)- Glucocorticoid receptor signaling; apoptosis and the immune system Anthony P. Davenport, UK (Chair Evolving Pharmacology, GPCRs Liaison) Doriano Fabbro, Switzerland - Kinases and their biology, kinase inhibitors, drug discovery, pharmacology of drugs (kinase inhibitors) in the indication oncology, biology of oncology Kozo Kaibuchi, Japan Yoshikatsu Kanai, Japan - Transporters, amino acid signals, epithelial function, cancer biology Francesca Levi - Schaffer, Israel - eosinophils and mast cells as effector cells in allergic inflammation: characterization of new receptors / ligands, hypoxia / angiogenesis and eosinophils, asthma, atopic dermatitis, allergic rhinitis, immunopharmacological modulation of allergic diseases by bispecific recombinant antibodies, bacteria interactions with eosinophils and mast cells, the allergic effector unit, mast cell derived tumors: new antibody based treatment, the allergic inflammation and the resolvome, non IgE - mediated mast cell activation in diseases Eliot H. Ohlstein, USA (Editor)- Drug discovery and development, urogenital biology, cardiovascular / metabolic medicine John A. Peters, UK (LGICs Liaison) Alex Phipps, UK - Oncology, Clinical Pharmacology, Biologics and Immunotherapy Joerg Striessnig, Austria (VGICs Liaison)- Physiology, pharmacology and pathophysiological role of voltage-gated calcium chandrug discovery, pharmacology of drugs (kinase inhibitors) in the indication oncology, biology of oncology Kozo Kaibuchi, Japan Yoshikatsu Kanai, Japan - Transporters, amino acid signals, epithelial function, cancer biology Francesca Levi - Schaffer, Israel - eosinophils and mast cells as effector cells in allergic inflammation: characterization of new receptors / ligands, hypoxia / angiogenesis and eosinophils, asthma, atopic dermatitis, allergic rhinitis, immunopharmacological modulation of allergic diseases by bispecific recombinant antibodies, bacteria interactions with eosinophils and mast cells, the allergic effector unit, mast cell derived tumors: new antibody based treatment, the allergic inflammation and the resolvome, non IgE - mediated mast cell activation in diseases Eliot H. Ohlstein, USA (Editor)- Drug discovery and development, urogenital biology, cardiovascular / metabolic medicine John A. Peters, UK (LGICs Liaison) Alex Phipps, UK - Oncology, Clinical Pharmacology, Biologics and Immunotherapy Joerg Striessnig, Austria (VGICs Liaison)- Physiology, pharmacology and pathophysiological role of voltage-gated calcium chanDrug discovery and development, urogenital biology, cardiovascular / metabolic medicine John A. Peters, UK (LGICs Liaison) Alex Phipps, UK - Oncology, Clinical Pharmacology, Biologics and Immunotherapy Joerg Striessnig, Austria (VGICs Liaison)- Physiology, pharmacology and pathophysiological role of voltage-gated calcium channels

One of the principal goals in the development of new methods for treating asthma is therefore to identify non-steroidal drugs that can effectively control the inflammatory response underlying asthma symptoms.

From their success in revealing the basic mechanisms of asthma, six new drugs have entered clinical testing for asthma, many others are in pre-clinical testing, and scores of new molecular pathways underlying asthma have been revealed.

January 20, 2015 Drug - development grants focus on sleep apnea, asthma research Two research teams based at the University of Chicago have received prestigious grants from the National Institutes of Health to develop novel medications to treat sleep apnea and asthma.

These drugs, introduced in 1998, were the first new type of treatment of asthma in 20 years.